Could a milk thistle extract help Parkinson's patients?

NCT ID NCT07001150

First seen Jun 25, 2026 · Last updated Jun 26, 2026 · Updated 1 time

Summary

This Phase 2 trial is testing whether silymarin, an antioxidant from milk thistle, can protect brain cells and improve symptoms in people with Parkinson's disease. Researchers will give 50 adults either silymarin or a placebo alongside their usual Parkinson's medications. The goal is to see if silymarin can slow the disease's progression and ease movement problems.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
silymarin (milk thistle extract)
What this could lead to
If it works, this could point toward a new way to slow Parkinson's progression and improve symptom control when added to standard treatment.
What could go wrong
This is a small, early Phase 2 trial, so results may not apply to everyone. Silymarin is generally safe, but it may not provide meaningful benefit for Parkinson's symptoms or nerve protection.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PARKINSON DISEASE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Tanta Hospital for Mental Health

    RECRUITING

    Tanta, Tanta, Qism 2, 31511, Egypt

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

More trials for these conditions

Other studies related to the condition(s) this trial covers.